FDA Approved: TACROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tacrolimus by Mylan Pharmaceuticals Inc., enabling changes to its labeling. This relates to the generic immunosu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Kidney Transplant
• Liver Transplant
• Pancreas Transplant

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)